DYN – dyne therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Paragon Therapeutics Appoints Susanna High as Chief Executive Officer [Yahoo! Finance]
Dyne Therapeutics, Inc. (NASDAQ: DYN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $50.00 price target on the stock.
Dyne Therapeutics, Inc. (NASDAQ: DYN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Dyne Therapeutics to Present at Upcoming Investor Conferences
Form 4 Dyne Therapeutics, Inc. For: Nov 18 Filed by: Incerti Carlo
Form 4 Dyne Therapeutics, Inc. For: Nov 14 Filed by: Rhodes Jason P
Form 144 Dyne Therapeutics, Inc. Filed by: Incerti Carlo
Form 4 Dyne Therapeutics, Inc. For: Nov 18 Filed by: Scalzo Richard William
Form 4 Dyne Therapeutics, Inc. For: Nov 18 Filed by: Beskrovnaya Oxana
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.